Immune Dysregulation
Showing 9976 - 10000 of >10,000
X-linked Severe Combined Immunodeficiency Trial in London (Single infusion of autologous CD34+ cells transduced with the
Unknown status
- X-linked Severe Combined Immunodeficiency
- Single infusion of autologous CD34+ cells transduced with the self-inactivating (SIN) gammaretroviral vector pSRS11.EFS.IL2RG.pre
-
London, United KingdomGreat Ormond Street Hospital for Children NHS Trust
Jul 31, 2017
Multiple Sclerosis Trial in Tehran (intravenous injection of mesenchymal stem cells, injection of cell free media)
Completed
- Multiple Sclerosis
- intravenous injection of mesenchymal stem cells
- injection of cell free media
-
Tehran, Iran, Islamic Republic ofRoyan Institute
Mar 6, 2018
AMP-514 in Blood Samples From Solid Tumors Undergoing
Completed
- Unspecified Adult Solid Tumor, Protocol Specific
- Cytology specimen
- Laboratory biomarker analysis
-
Philadelphia, PennsylvaniaThomas Jefferson University
Sep 5, 2017
Prostate Cancer Trial in United States (PROSTVAC®-VF/TRICOM™)
Completed
- Prostate Cancer
- PROSTVAC®-VF/TRICOM™
-
Homewood, Alabama
- +46 more
Sep 7, 2017
Nicotine Addiction, Cigarette Smoking Trial in Stony Brook (Nicotine, MR Compatible Nicotine Delivery Device)
Unknown status
- Nicotine Addiction
- Cigarette Smoking
- Nicotine
- MR Compatible Nicotine Delivery Device
-
Stony Brook, New YorkBioengineering Building , Stony Brook University
Jun 29, 2017
Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Stage IA Breast Cancer Trial in Seattle (drug,
Completed
- Estrogen Receptor-positive Breast Cancer
- +8 more
- doxorubicin hydrochloride
- +6 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Aug 30, 2017
Behaviour Trial in Oxford (Bimuno (BGOS), Maltodextrin)
Unknown status
- Behaviour
- Bimuno (BGOS)
- Maltodextrin
-
Oxford, Oxfordshire, United KingdomOxford University Department of Psychiatry
Mar 14, 2018
Chronic Lymphocytic Leukemia, GVHD, Hodgkin's Disease Trial run by the NCI (Th2 cells in allo HSCTT, Th2 Cells)
Completed
- Chronic Lymphocytic Leukemia
- +4 more
- Th2 cells in allo HSCTT
- Th2 Cells
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jul 3, 2018
Steroid Replacement Therapy in Septic Shock
Unknown status
- Septic Shock
- Aldosterone / renin dosage
- Natriuresis
-
Dijon, FranceChu Dijon Bourgogne
Aug 21, 2017
Dietary Modification Trial (GOS, B-GOS 3%, B-GOS 2%)
Completed
- Dietary Modification
- GOS
- +3 more
- (no location specified)
Jul 17, 2017
Motion Immune Magnetic Resonance Imaging (MRI)
Completed
- Parkinson's Disease
- Multiplex Sensitivity Encoding (MUSE)
-
Durham, North CarolinaDuke University Medical Center
Aug 10, 2017
Alzheimer's Disease Trial in Portland (Lipoic acid and fish oil concentrate, Placebo)
Completed
- Alzheimer's Disease
- Lipoic acid and fish oil concentrate
- Placebo
-
Portland, OregonOregon Health & Science University
Mar 1, 2017
Glioblastoma Platelet Activation Study
Completed
- Glioblastoma
- Circulating Platelet-monocyte Conjugates
-
Greifswald, GermanyDepartment of Neurosurgery
Jul 31, 2017
Lymphocyte Counts in Immune Thrombocytopenic Purpura
Unknown status
- Thrombocytopenic Purpura
- complete blood picture
- (no location specified)
Aug 7, 2017
Primary Immune Deficiency Disorder Trial in Caen (Internal Medicine consultation)
Unknown status
- Primary Immune Deficiency Disorder
- Internal Medicine consultation
-
Caen, FranceCaen University Hospital
Aug 16, 2017
Ataxia Telangiectasia Trial in Frankfurt (bioelectrical impedance analysis, blood draw, transient elastography (FibroScan))
Unknown status
- Ataxia Telangiectasia
- bioelectrical impedance analysis
- +4 more
-
Frankfurt, Hessen, GermanyChildren's Hospital, Allergology, Pneumology and Cystic Fibrosis
Nov 29, 2017
Recurrent Bladder Carcinoma, Stage II Bladder Cancer, Stage III Bladder Cancer Trial in Seattle (Cisplatin, Gemcitabine
Completed
- Recurrent Bladder Carcinoma
- +3 more
- Cisplatin
- +3 more
-
Seattle, Washington
- +1 more
Sep 20, 2017
Serum miRNA-30a in Childhood Nephrotic Syndrome
Unknown status
- Nephrotic Syndrome Steroid-Resistant
- ‗Urine analysis ‗Urine protein quantification ‗Serum albumin ‗Lipid profile.Quantitation of miRNA -30a by Real-time polymerase chain reaction (Q-PCR) in peripheral blood.
- (no location specified)
Aug 1, 2017
Healthy NIH Employees at Baseline and After Immunization With
Completed
- Healthy Volunteers
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 5, 2017
Immunopathogenesis of Food Allergy and Eosinophilic
Terminated
- Eosinophilic Gastroenteritis
- Eosinophilic Esophagitis
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 5, 2017
Neurotoxicity Trial in Chandigarh (Anesthetic Agents)
Completed
- Neurotoxicity
- Anesthetic Agents
-
Chandigarh, IndiaPostgraduate Institute of Medical Education and Research
Sep 18, 2017
Ulcerative Colitis Trial in Rennes (Probiotics in the form of cheese portion)
Terminated
- Ulcerative Colitis
- Probiotics in the form of cheese portion
-
Rennes, FranceCHU de Rennes
Jul 3, 2017
Intraocular Melanoma, Malignant Conjunctival Tumor, Melanoma (Skin) Trial in Pittsburgh (Peptide vaccine, GM-CSF, PF3512676)
Completed
- Intraocular Melanoma
- +2 more
- Peptide vaccine
- +2 more
-
Pittsburgh, PennsylvaniaUPMC Cancer Centers
Jun 21, 2017
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Detroit (biological, drug, radiation)
Completed
- Chronic Myeloproliferative Disorders
- +5 more
- rituximab
- +9 more
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
May 26, 2017
Cytomegalovirus Infection, Healthy, no Evidence of Disease Trial in Duarte (multi-CMV epitope modified vaccinia Ankara vaccine,
Completed
- Cytomegalovirus Infection
- Healthy, no Evidence of Disease
- multi-CMV epitope modified vaccinia Ankara vaccine
- laboratory biomarker analysis
-
Duarte, CaliforniaCity of Hope Medical Center
Jul 31, 2017